These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Trans-splicing vectors expand the packaging limits of adeno-associated virus for gene therapy applications. Duan D; Yue Y; Yan Z; Engelhardt JF Methods Mol Med; 2003; 76():287-307. PubMed ID: 12526170 [No Abstract] [Full Text] [Related]
3. Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids. Chamberlain K; Riyad JM; Weber T Hum Gene Ther Methods; 2016 Feb; 27(1):1-12. PubMed ID: 26757051 [TBL] [Abstract][Full Text] [Related]
4. Novel tools for production and purification of recombinant adenoassociated virus vectors. Grimm D; Kern A; Rittner K; Kleinschmidt JA Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273 [TBL] [Abstract][Full Text] [Related]
5. Development and optimization of adeno-associated virus vector transfer into the central nervous system. During MJ; Young D; Baer K; Lawlor P; Klugmann M Methods Mol Med; 2003; 76():221-36. PubMed ID: 12526166 [No Abstract] [Full Text] [Related]
6. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Dong JY; Fan PD; Frizzell RA Hum Gene Ther; 1996 Nov; 7(17):2101-12. PubMed ID: 8934224 [TBL] [Abstract][Full Text] [Related]
10. Site-specific integration of an adeno-associated virus vector plasmid mediated by regulated expression of rep based on Cre-loxP recombination. Satoh W; Hirai Y; Tamayose K; Shimada T J Virol; 2000 Nov; 74(22):10631-8. PubMed ID: 11044107 [TBL] [Abstract][Full Text] [Related]
11. AAV as a viral vector for human gene therapy. Generation of recombinant virus. Rolling F; Samulski RJ Mol Biotechnol; 1995 Feb; 3(1):9-15. PubMed ID: 7606507 [TBL] [Abstract][Full Text] [Related]
13. AAV6 Vector Production and Purification for Muscle Gene Therapy. Halbert CL; Allen JM; Chamberlain JS Methods Mol Biol; 2018; 1687():257-266. PubMed ID: 29067669 [TBL] [Abstract][Full Text] [Related]
14. Optimization of packaging of adeno-associated virus gene therapy vectors using plasmid transfections. Chirico J; Trempe JP J Virol Methods; 1998 Dec; 76(1-2):31-41. PubMed ID: 9923737 [TBL] [Abstract][Full Text] [Related]
15. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors. Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115 [TBL] [Abstract][Full Text] [Related]
16. Development of packaging cell lines for generation of adeno-associated virus vectors by lentiviral gene transfer of trans-complementary components. Nakamura S; Nakamura R; Shibata K; Kobayashi M; Sahara N; Shigeno K; Shinjo K; Naito K; Ohnishi K; Kasahara N; Iwaki Y Eur J Haematol; 2004 Oct; 73(4):285-94. PubMed ID: 15347316 [TBL] [Abstract][Full Text] [Related]
17. Potential use of cellular promoter(s) to target RPE in AAV-mediated delivery. Cellular promoters and RPE-targeting. Sutanto EN; Zhang D; Lai YK; Shen WY; Rakoczy PE Adv Exp Med Biol; 2006; 572():267-73. PubMed ID: 17249583 [No Abstract] [Full Text] [Related]
18. Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo. Gao G; Qu G; Burnham MS; Huang J; Chirmule N; Joshi B; Yu QC; Marsh JA; Conceicao CM; Wilson JM Hum Gene Ther; 2000 Oct; 11(15):2079-91. PubMed ID: 11044910 [TBL] [Abstract][Full Text] [Related]
19. Novel tools for production and purification of recombinant adeno-associated viral vectors. Harris JD; Beattie SG; Dickson JG Methods Mol Med; 2003; 76():255-67. PubMed ID: 12526168 [No Abstract] [Full Text] [Related]
20. Small and Micro-Scale Recombinant Adeno-Associated Virus Production and Purification for Ocular Gene Therapy Applications. Reid CA; Lipinski DM Methods Mol Biol; 2018; 1715():19-31. PubMed ID: 29188503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]